GenTel to distribute cancer research tool ( Madison Wis.

(Date:5/16/2008)...- Campbell Alliance, the leading,management consul...iotech,industry, today announced that it will pres...d Biotech Trainers (SPBT) Annual Conference to be ...arriott in Orlando, Florida., On Wednesday, May 2...e,Sales Practice, will present a workshop entitled...

(Date:5/16/2008)...ba Therapeutics Corporation,announced today that i... a,twelve-week Phase IIb trial with oral larazotid...unction, for the treatment of patients with active...domized, double-blind,placebo-controlled study wi..., safety and tolerability of larazotide acetate in...

(Date:5/16/2008)...l/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ON...rim,results of a Phase II study of intravenous REO...he lung is available on the American Society of,Cl....org and on the Oncolytics,website at http://www..."A Phase II,Study of Intravenous REOLYSIN (Wild-ty...

(Date:5/15/2008)...May 16 /-,Bayer HealthCare ...c.,(Nasdaq: ONXX ) today announced more than 40 d...Clinical Oncology (ASCO) annual meeting demonstrat...ts in multiple tumor types as,a single agent or in...ll expand upon and support the proven efficacy and...

Breaking Biology Technology:Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference 2 Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference 3 Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 2 Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 3 Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 2 Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 2 Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 3 Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 4 Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 5 Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 6 Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 7

[0] Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference [0] Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease [0] Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting [0] Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting

...nsin in Milwaukee and the University of Wisconsi...ormation about collaborative research opportunitie...al College statement on Wednesday. , ,The medical ...also in on the agreement MCW Research Foundation...ion plan to share industry contacts and collabora...

...e governor and the Legislature are bogged down in ...sconsin. Money is tight, just as it is in Wisconsi...e two states: In Minnesota, the university budget ... of perpetual friction as it is in Wisconsin. , ,A...nty are behind schedule in most ways in their budg...

...life science companies have another chance to stre...d Friday at the MG&E Innovation Center. , ,Sponsor...JETRO, the gathering will offer attendees an insid...rtnering with similar companies in Japan. Executiv...difficulties and rewards of doing business there, ...

...able 24 hours a day now that a new company has cre...he Web site MusicMadeInMadison.com plays more th...cians such as the Profits, Daedalus Burn, Infinite...005 by Regional Radio, LLC, the site,s goal is to ...ness of Madison,s independent music community. , ,...

Other Biology Technology:Feuds between UW and the Legislature should end for good of the state 2 Feuds between UW and the Legislature should end for good of the state 3 Wisconsin biotechs plan Japan trade mission 2

Madison, Milwaukee med schools to collaborate on tech transfer Feuds between UW and the Legislature should end for good of the state Wisconsin biotechs plan Japan trade mission Madison music featured on Internet radio station

(Date:5/15/2008)...on is supposed to inch forward over eons, but some...d the threespine stickleback, the process can go i...y led by researchers at Fred Hutchinson Cancer Res...n the May 20 issue of Current Biology (Cell Press)...erse evolution in nature, said senior author Cathe...

(Date:5/15/2008)...--Having found that whether bacteria stick to surf...e, MIT engineers have created ultrathin films made...ces and other surfaces to control microbe accumula...ould provide a valuable layer of protection for th...read of hospital-acquired infections, which take t...

(Date:5/15/2008)...--MIT engineers have improved the power output of ...ugh technology that could help these environmental...ader market, particularly in portable electronics....iderably less expensive than its conventional indu...r goal is to replace traditional fuel-cell membran...

(Date:5/15/2008)...ching a football. Maneuvering through a room full ...lls fore. Most would agree these seemingly simple ... to a situation. Assistant Professor of Cognitive ...hangizi argues they require something moreour abil...nearly one-tenth of a second to translate the ligh...

[0] Researchers document rapid, dramatic 'reverse evolution' in the threespine stickleback fish [0] MIT crafts bacteria-resistant films [0] MIT creates new material for fuel cells [1] Crystal (eye) ball: Study says visual system equipped with 'future seeing powers'

... much as patients would like for the word "doctor"...ever be the case. Human fallibility on the part of...ing misdiagnoses that can result in additional suf...here is hope for better, more accurate medical dia..., and one Florida State University researcher is p...

... searching for ways to counteract the greenhouse e... culprit---carbon dioxide---as it is emitted from ...g it into the ocean. But there are pitfalls in tha...surface, turn into gas bubbles and vent to the atm...scheme. Even worse, if the liquid-to-gas conversio...

...e risk of human bird flu infection is small in Aus... keep pet birds, according to bird medicine specia...rd flu off a pet bird or your neighbours birds are...y Science Adjunct Professor Dr Doneley said. , "...meteor and fall on your head than somebody getting...

...w research has shown that the immune-stimulating h...be administered with interferon, another immune-sy...cancers. , Normally, interferon is used alone to ...ers. This strategy, a form of immunotherapy, is so...ncer and other tumors that respond poorly to chemo...

Other Biology News:Making medicine 'smarter' 2 Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect 2 Expert dispels bird flu paranoia 2 Study shows combination of immune substances to be safe 2

Making medicine 'smarter'Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect Expert dispels bird flu paranoia Study shows combination of immune substances to be safe

Umbilical cord blood neutrophils, For immunohistochemistry (IHC)

Isotetrandrine from Calbiochem

Suramin, Sodium Salt from Calbiochem

cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio

Biology Products:

UCB Neutrophil Chip-IHC from 3H Biomedical AB Isotetrandrine from Calbiochem Suramin, Sodium Salt from Calbiochem cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio

( Madison Wis. - A research tool from ...)GenTel to distribute cancer research tool